MedPath

Study in patients with plantar viral warts treated with topical bleomycin orbleomycin and electrochemotherapy

Conditions
viral wart
Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
Registration Number
EUCTR2014-003339-21-ES
Lead Sponsor
Institut d'Investigació Sanitària Pere Virgili (IISPV)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

a) Age ? 18 years.
b) Signed informed consent.
c) Histological confirmation of wart / s plantar / is viral / s.
d) Patients belonging to the area of specialized care of Dermatology Department of Pius Hospital de Valls.
e) Failure of previous conventional treatments (cryosurgery, surgery, electrocautery, topical immunomodulators).
f) Minimum size of the plantar wart: 0.5 cm.
g) Presence of single lesion or multiple lesions equal to or greater than 3 cm distance between them in the foot (both included).
h) Ability of patients to follow instructions
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 84
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 84

Exclusion Criteria

a) Background Raynauld phenomenon, peripheral vascular disease or collagen disease known.
b) known heart disease
c) Previous use of bleomycin
d) No informed consent signed or removal thereof
e) Pregnancy or lactation

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath